Jennifer Adair to Tumor Suppressor Proteins
This is a "connection" page, showing publications Jennifer Adair has written about Tumor Suppressor Proteins.
Connection Strength
0.248
-
Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL, Bridge CA, Hawkins-Daarud A, Gori JL, Born DE, Gonzalez-Cuyar LF, Silbergeld DL, Rockne RC, Storer BE, Rockhill JK, Swanson KR, Kiem HP. Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients. J Clin Invest. 2014 Sep; 124(9):4082-92.
Score: 0.106
-
Adair JE, Beard BC, Trobridge GD, Neff T, Rockhill JK, Silbergeld DL, Mrugala MM, Kiem HP. Extended survival of glioblastoma patients after chemoprotective HSC gene therapy. Sci Transl Med. 2012 May 09; 4(133):133ra57.
Score: 0.091
-
Burtner CR, Chandrasekaran D, Santos EB, Beard BC, Adair JE, Hamlin DK, Wilbur DS, Sandmaier BM, Kiem HP. (211)Astatine-Conjugated Monoclonal CD45 Antibody-Based Nonmyeloablative Conditioning for Stem Cell Gene Therapy. Hum Gene Ther. 2015 Jun; 26(6):399-406.
Score: 0.028
-
Mrugala MM, Adair J, Kiem HP. Chemoprotection in glioblastoma therapy: reality or a dream? CNS Oncol. 2012 Sep; 1(1):11-4.
Score: 0.023